Bortolotti, Sonia; Angelucci, Silvia; Montemurro, Luca; Bartolucci, Damiano; Raieli, Salvatore; Lampis, Silvia; Amadesi, Camilla; Scardovi, Annalisa; Nieddu, Giammario; Cerisoli, Lucia; Paganelli, Francesca; Chiarini, Francesca; Teti, Gabriella; Falconi, Mirella; Pession, Andrea; Hrelia, Patrizia; Tonelli, Roberto, Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance, «CANCERS», 2023, 15, pp. 990 - 1007 [articolo]Open Access
Bartolucci D.; Montemurro L.; Raieli S.; Lampis S.; Pession A.; Hrelia P.; Tonelli R., MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment, «CANCERS», 2022, 14, Article number: 4421, pp. 1 - 29 [articolo]Open Access
Bartolucci D.; Pession A.; Hrelia P.; Tonelli R., Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs, «PHARMACEUTICS», 2022, 14, Article number: 1453, pp. 1 - 23 [articolo]Open Access
Lampis S.; Raieli S.; Montemurro L.; Bartolucci D.; Amadesi C.; Bortolotti S.; Angelucci S.; Scardovi A.L.; Nieddu G.; Cerisoli L.; Paganelli F.; Valente S.; Fischer M.; Martelli A.M.; Pasquinelli G.; Pession A.; Hrelia P.; Tonelli R., The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2022, 41, Article number: 160, pp. 160 - 179 [articolo]Open Access
Raieli S.; Di Renzo D.; Lampis S.; Amadesi C.; Montemurro L.; Pession A.; Hrelia P.; Fischer M.; Tonelli R., MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma, «FRONTIERS IN ONCOLOGY», 2021, 11, Article number: 625207, pp. 1 - 12 [articolo]Open Access
Moreno L.; Barone G.; DuBois S.G.; Molenaar J.; Fischer M.; Schulte J.; Eggert A.; Schleiermacher G.; Speleman F.; Chesler L.; Geoerger B.; Hogarty M.D.; Irwin M.S.; Bird N.; Blanchard G.B.; Buckland S.; Caron H.; Davis S.; De Wilde B.; Deubzer H.E.; Dolman E.; Eilers M.; George R.E.; George S.; Jaroslav; Maris J.M.; Marshall L.; Merchant M.; Mortimer P.; Owens C.; Philpott A.; Poon E.; Shay J.W.; Tonelli R.; Valteau-Couanet D.; Vassal G.; Park J.R.; Pearson A.D.J., Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma, «EUROPEAN JOURNAL OF CANCER», 2020, 136, pp. 52 - 68 [articolo]
Montemurro L.; Raieli S.; Angelucci S.; Bartolucci D.; Amadesi C.; Lampis S.; Scardovi A.L.; Venturelli L.; Nieddu G.; Cerisoli L.; Fischer M.; Teti G.; Falconi M.; Pession A.; Hrelia P.; Tonelli R., A novel MYCN-specific antigene oligonucleotide deregulates mitochondria and inhibits tumor growth in MYCN-amplified neuroblastoma, «CANCER RESEARCH», 2019, 79, pp. 6166 - 6177 [articolo]Open Access
A. Astolfi; F. Vendemini; M. Urbini; F. Melchionda; R. Masetti; M. Franzoni; V. Libri; S. Serravalle; M. Togni; L. Montemurro; R. Rondelli; G. Paone; D. Bressanin; F. Chiarini; A.M. Martelli; R. Tonelli; A. Pession., MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia, «ONCOTARGET», 2014, 5, pp. 120 - 130 [articolo]
Bergantin E; Quarta C; Nanni C; Fanti S; Pession A; Cantelli-Forti G; Tonelli R; Hrelia P, Sulforaphane induces apoptosis in rhabdomyosarcoma and restores TRAIL-sensitivity in the aggressive alveolar subtype leading to tumor elimination in mice., «CANCER BIOLOGY & THERAPY», 2014, 15, pp. 1219 - 1225 [articolo]
Carmelo Quarta; Erika Cantelli; Cristina Nanni; Valentina Ambrosini; Daniela D’ambrosio; Korinne Di Leo; Silvia Angelucci; Federico Zagni; Filippo Lodi; Mario Marengo; William A. Weiss; Andrea Pession; Roberto Tonelli; Stefano Fanti, Molecular Imaging of Neuroblastoma
Progression in TH-MYCN Transgenic Mice, «MOLECULAR IMAGING AND BIOLOGY», 2013, 15(2), pp. 194 - 202 [articolo]
R. Tonelli; A. McIntyre; C. Camerin; Z.S. Walters; K. Di Leo; J. Selfe; S. Purgato; E. Missiaglia; A. Tortori; J. Renshaw; A. Astolfi; K.R. Taylor; S. Serravalle; R. Bishop; C. Nanni; L.J. Valentijn; A. Faccini; I. Leuschner; S. Formica; Jorge S Reis-Filho9; V. Ambrosini; K. Thway; M. Franzoni; B. Summersgill; R. Marchelli; P. Hrelia; G. Cantelli-Forti; S. Fanti; R. Corradini; A. Pession; J. Shipley, Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy, «CLINICAL CANCER RESEARCH», 2012, 18, pp. 796 - 807 [articolo]
D MONTAGNA; I TURIN; R SCHIAVO; E MONTINI;
N ZAFFARONI; R VILLA; S SECONDINO;
I SCHIAVETTO; L CALIOGNA; F LOCATELLI;
VIRGINIA LIBRI; ANDREA PESSION; R TONELLI; R MACCARIO;
S SIENA; P PEDRAZZOLI, Feasibility and safety of adoptive immunotherapy with ex vivogenerated
autologous, cytotoxic T lymphocytes in patients with
solid tumor, «CYTOTHERAPY», 2012, 14, pp. 80 - 90 [articolo]
FAZZINA R.; LOMBARDINI L.; MEZZANOTTE L.; RODA A.; HRELIA P; PESSION A.; TONELLI R., Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles, «INTERNATIONAL JOURNAL OF ONCOLOGY», 2012, 41, pp. 621 - 628 [articolo]
M. Dekker; S. de Vries; M. Aarts; R. Dekker; C Brouwersa;
O. Wiebenga; N. de Wind; E. Cantelli; R. Tonelli; H te Riele, Transient suppression of MLH1 allows effective single-nucleotide substitution
by single-stranded DNA oligonucleotides, «MUTATION RESEARCH», 2011, 715, pp. 52 - 60 [articolo]
Sforza S.; Tedeschi T.; Calabretta A.; Corradini R.; Camerin C.; Tonelli R.; Pession A.; Marchelli R., A Peptide Nucleic Acid Embedding a Pseudopeptide Nuclear Localization Sequence in the Backbone Behaves as a Peptide Mimic, «EUROPEAN JOURNAL OF ORGANIC CHEMISTRY», 2010, 13, pp. 2441 - 2444 [articolo]
